ScaleUp Bio

ScaleUp Bio has secured a food manufacturing license from the Singapore Food Agency (SFA) for its commercial pilot production facility in Tuas, western Singapore. 

Image courtesy of ScaleUp Bio
Cultivated, Cell-Cultured & Biotechnology

ADM’s ScaleUp Bio Secures Food Manufacturing License for Novel Proteins in Singapore

ScaleUp Bio, Singapore’s pioneer provider of CDMO services for microbial and precision fermentation, has secured a food manufacturing license from the Singapore Food Agency (SFA) for its commercial pilot production facility in Tuas, western Singapore.  The FSA ensures that food production practices meet established safety standards by inspecting infrastructure and facilities. It also requires proper training, collaboration, and regulatory adherence to maintain high hygiene and operational quality levels. The company states that this milestone positions it as one of the few approved CDMOs offering fermentation services at 10,000 L for food ingredients worldwide. Francisco Codoñer, CEO of ScaleUp Bio, shares, “ScaleUp Bio’s value proposition offers anyone with the next best concept in food to bring that idea to reality, and to pilot stage commercial production in Singapore, backed by a …

more

ADM's new alt protein report identifies four focus factors for the sector's growth

Image courtesy of ADM
Company News

Precision Fermentation CDMO ScaleUp Bio Announces First Customers, Signaling Opportunities for Novel Foods in Asia

ScaleUp Bio, Singapore’s pioneer provider of CDMO services for microbial precision fermentation, announces its first customers, including the Australian food tech company Nourish Ingredients.   Established in 2022 as a joint venture company of ADM and Nurasa, ScaleUp Bio provides a pathway from bench-to-market pipeline and facilitates entry into Asian markets and other regions. ScaleUp Bio’s agreement collaboration with Nourish Ingredients will support 10,000 L of fermentation capacity and 100 L of thermal processing. The Australian company will establish in Singapore a strategic Asia Pacific hub for scaling production of its animal-free fat (Tastilux) for plant-based meat and other applications.  ScaleUp Bio has also signed Letters of Intent with US biotech C16 Biosciences, which produces an alternative to the ubiquitous palm oil to reduce its environmental and carbon footprint; the Malaysian plant-based meat …

more